About Jeffrey Tong
Jeffrey Tong is a director at Septerna.
Jeffrey Tong reports to the SEC as a director, officer or major shareholder of 5 public companies, including Maze Therapeutics (MAZE), Rapport Therapeutics (RAPP) and Nurix Therapeutics (NRIX).
Jeffrey Tong first appears on SEC filings in 2010.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Tong in the role, so the role may have started earlier or lasted longer.
MI
Maze Therapeutics, Inc.
Director
2025 · Public company (MAZE)
RI
Rapport Therapeutics, Inc.
Director
2024 · Public company (RAPP)
NI
Nurix Therapeutics, Inc.
Director and 10% owner
2020 – 2021 · Public company (NRIX)
II
Infinity Pharmaceuticals, Inc.
VP, Cor. & Product Development
2010 · Public company (INFI)
Key Colleagues at Startups
The people Jeffrey Tong works with at each company, as listed on that company's latest Form D.
Septerna, Inc. · Form D, Jul 13, 2023
AE
Alan Ezekowitz
Director
RX
Ran Xiao
Executive officer
EB
Elizabeth Bhatt
Executive officer
JS
Jake Simson
Director
AB
Abraham Bassan
Director
JF
Jeffrey Finer
Chief Executive Officer and director
SS
Samira Shaikhly
Executive officer